Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

NCT03821623 is registered in ClinicalTrials.gov with Douglas Seals as lead sponsor.

NCT NCT03821623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
Lead sponsor
Douglas Seals
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 10, 2019
Completion date
October 1, 2027
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, hypertension